ID: ALA1762476

Max Phase: Preclinical

Molecular Formula: C20H22N2O6

Molecular Weight: 296.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNCC[C@@H](Oc1cc(OC)ccc1C#N)c1ccccc1.O=C(O)C(=O)O

Standard InChI:  InChI=1S/C18H20N2O2.C2H2O4/c1-20-11-10-17(14-6-4-3-5-7-14)22-18-12-16(21-2)9-8-15(18)13-19;3-1(4)2(5)6/h3-9,12,17,20H,10-11H2,1-2H3;(H,3,4)(H,5,6)/t17-;/m1./s1

Standard InChI Key:  FCJZJQBLFVEPPT-UNTBIKODSA-N

Associated Targets(Human)

Nitric oxide sythases; iNOS & nNOS 685 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Norepinephrine transporter 10102 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin transporter 12625 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2D6 33882 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nitric oxide synthase, inducible 1636 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.37Molecular Weight (Monoisotopic): 296.1525AlogP: 3.30#Rotatable Bonds: 7
Polar Surface Area: 54.28Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.80CX LogP: 2.99CX LogD: 0.65
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.34

References

1. Cheshire DR, Åberg A, Andersson GM, Andrews G, Beaton HG, Birkinshaw TN, Boughton-Smith N, Connolly S, Cook TR, Cooper A, Cooper SL, Cox D, Dixon J, Gensmantel N, Hamley PJ, Harrison R, Hartopp P, Käck H, Leeson PD, Luker T, Mete A, Millichip I, Nicholls DJ, Pimm AD, St-Gallay SA, Wallace AV..  (2011)  The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).,  21  (8): [PMID:21398123] [10.1016/j.bmcl.2011.02.061]

Source